London Life Sciences Week: connecting the global biotech community

Steve Bates Headshot.png

London Life Sciences Week united the global biotech community for a dynamic week of networking and dealmaking. The BIA representatives were out and about throughout the week, networking with members and stakeholders. In this blog, Steve Bates OBE, CEO of BioIndustry Association, summarises insights based on the BIA team's first-hand experience.

London Life Sciences Week is an annual event that brings together the global biotech community for a week of networking and dealmaking. The event is centered on the Jefferies Healthcare Conference, but also includes a growing number of satellite events, this year incorporating the BIA/BioCentury CEO Investor event, the Citeline Elevate Summit and Scrip awards, and the LSX Investival Showcase and Lifestars Awards.

This year's London Life Sciences Week took place 14-16 November 2023, creating an amazing buzz and, attracting a record number of global visitors. The BIA were out and about throughout the week, networking with members and stakeholders.

A highlight was the HSBC Innovation Banking party, announcing themselves as a key sector player, particularly given the BIA’s role in securing the Silicon Valley Bank rescue package.

The Jefferies Healthcare Conference is the centrepiece of London Life Sciences Week. The conference is known for its company presentations, investor introductions and panel discussions covering a wide range of topics, from the latest trends in drug discovery and development to the challenges and opportunities facing the biotech industry.

This year's Jefferies Healthcare Conference featured presentations from leading companies such as AstraZeneca, GlaxoSmithKline and Roche. The conference also featured several breakout sessions on topics such as precision medicine, personalised healthcare, and data analytics.

BioCentury/BIA event
BioCentury/BIA panel: Why UK biotech is ready to breakout​
Citeline Elevate fireside chat.PNG
Citeline Elevate fireside chat

Satellite events

In addition to the Jefferies Healthcare Conference, London Life Sciences Week also included a number of vibrant satellite events. These events provided additional opportunities for networking, learning, and dealmaking. And connectivity was immense.

Some of the highlights of this year's satellite events included:

  • The BIA/BioCentury CEO Investor event, which brought together investors and biotech leaders.
  • The Citeline Elevate Summit focused on successful commercial strategies.
  • The 2023 Scrip Awards, which recognised the outstanding accomplishments of those improving human healthcare worldwide including many BIA member companies, culminated in a Lifetime Achievement Award for Jeremy Levin who delivered an impactful reflection of the responsibilities of sector leadership.
  • Cooley Reception at Somerset House Spring Restaurant brought together a broad range of attendees including BIA members. 
  • The LSX Investival Showcase featured presentations from a number of promising life sciences companies.
  • The London IC Startup Series: Funding & Finance with Innovate UK KTN & Octopus Ventures, where Innovate UK’s funding and support programs were explained, and Octopus Ventures focused on how to connect with VCs.
  • The Pharma Integrates 2023 event brought together pharma and healthcare leaders across the Pharmaceutical pipeline.
  • SV Health Investors showcasing UK innovation at the Francis Crick Institute.
  • Abingworth giving companies and investors the opportunity to catch up over some very nice bottles of wine.
MicrosoftTeams-image (3).png 1
Laura Lane, Vice President, Lilly Ventures (Head of Europe), Eli Lilly and Company receiving an award at Scrip Awards
HSBC Innovation Banking reception at Sky Garden


SV health Investors Forum


Beyond Jefferies and its satellite events, a lot was going on that further showcased London as a global science hub. The new Lord Mayor of London, Michael Mainelli, also launched his Connect to Prosper campaign, which seeks to showcase London as a capital of science and culture, as well as finance. The British Science Association #ForThought event focused on science, innovation and national priorities. A thought-provoking first panel on the future of education and how the education system and assessment need to change to take advantage of AI and to ensure equitable access to digital skills. A second panel of the event delved deep into the future of health, unveiling insights from key figures: tackling ‘non-infectious’ conditions such as cancer, diabetes, and heart disease is key to addressing health inequalities in the UK.

London Life Sciences Week is a testament to the strength and growing prominence of the UK's biotech industry with innovation and collaboration at its core. BIA sees London Life Sciences Week as an increasingly important event connecting the global biotech community. We look forward to an even bigger and better event in 2024!

More news and updates 

ACROBiosystems launches the world’s first GMP-grade DLL-4 Protein

ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like Ligand 4, or DLL4, to be launched on the market under GMP conditions.

Investors-in-residence join Cancer Research Horizons to advance Ventures team

Jonathan Tobin, a partner at life science venture capital firm Brandon Capital, and Genghis Lloyd-Harris, a senior advisor at life sciences investment firm, Abingworth, have joined Cancer Research Horizons’ Ventures team as advisory investors-in-residence.

Milner, AstraZeneca, and MRC partner for functional genomics advancements

The University of Cambridge announced a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute.

RoslinCT to manufacture world’s-first CRISPR-based therapy

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration

CEO Update - 27 November 2023

Last week felt like an important milestone for the UK life science sector. As I sat in the Life Science Council in No 10 Downing Street with new Government Ministers, leaders of public institutions like the MHRA and global CEOs, I reflected that no other country in the world is putting together a working collaborative life science group like this.

Rosalind Franklin Institute appoints Professor Paul Matthews as new director

The Rosalind Franklin Institute announces Professor Paul Matthews as its new Institute Director. Professor Matthews is a world class clinician scientist with over 30 years of experience working on neurodegenerative disorders.

bioProcessUK: The role of candidate screening and feasibility studies

Ian Goodwin, Director of CMC Program Design in Advanced Therapies (covering Cell and Gene Therapy services) at FUJIFILM Diosynth Biotechnologies explores the benefits of candidate and feasibility studies to AAV production.

Brainomix expands to the US with FDA-cleared Stroke AI Platform

Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care.

Cancer Research Horizons opens nominations for its Innovation & Entrepreneurship Awards 2024

Cancer Research Horizons, the innovation arm of Cancer Research UK, has opened nominations for its Innovation & Entrepreneurship Awards 2024, which celebrate the UK’s most enterprising efforts in oncology.

Merit reaches key project milestone for Moderna's clinical laboratories

Northumberland-headquartered Merit, the UK’s leading industrialised construction and digital manufacturing specialist, has reached a significant project milestone for Moderna’s clinical laboratories project.

Autumn Statement 2023 analysis

The Chancellor has delivered a comprehensive package of investment and support for the UK life sciences industry in his Autumn Statement. In this blog, Dr Martin Turner, Head of Policy and Public Affairs at BIA shares his reflections on key announcements.

PrecisionLife announces new appointments to launch diagnostics and healthcare strategy

PrecisionLife® announces the appointment of Dr Gerald Dunstan as SVP Corporate Development and Hannah Bibby as Product Strategy Lead to drive the company’s expansion into precision diagnostics and personalized healthcare.

More within